HPV Vaccine and Cervical Cancer Prevention

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Women's Health Care".

Deadline for manuscript submissions: 31 October 2025 | Viewed by 1266

Special Issue Editor


E-Mail Website
Guest Editor
Brazilian National Cancer Institute, Clinical Research and Technological Development Division, Rio de Janeiro, RJ, Brazil
Interests: gynecological cancer; skin tumors; clinical research

Special Issue Information

Dear Colleagues,

Cervical cancer is a serious public health problem and represents the fourth most common cancer in women globally. The highest rates of cervical cancer incidence and mortality are in low- and middle-income countries driven by inequalities of access to HPV vaccination, screening and treatment services, and socioeconomic determinants. As demonstrated in many published clinical trials and epidemiological studies, HPV vaccination, screening, and the treatment of pre-invasive lesions are effective ways to prevent cervical cancer. In addition, cervical cancer can be cured if diagnosed and treated at an early stage of the disease. A commitment to eliminate cervical cancer as a public health problem follows the WHO global strategy with three targets (90% of girls vaccinated against HPV by age 15, 70% of women screened with a high-quality test, HPV test as primary screening, instead of conventional or liquid cytopathological examination, by ages 35 and 45, and 90% of women with cervical disease receiving treatment) to be achieved in 2030.

I am pleased to invite you to submit a paper to this Special Issue, titled “HPV Vaccine and Cervical Cancer Prevention”, with evidence-based recommendations focused on the current state of the art, health assessment, screening procedures, early diagnosis, long term outcomes, socioeconomic burden, etc.

This Special Issue aims to publish original review and research articles, including translational research and clinical and observational trials.

Research areas may include, but are not limited to, the following:

  • Modeling estimates of HPV vaccination impact;
  • Public awareness of HPV vaccination;
  • Access to HPV vaccination;
  • Information and services to prevention and control of cervical cancer;
  • Impact of HPV vaccination;
  • Screening in HPV vaccinated women;
  • Socioeconomic burden of HPV vaccination.

I look forward to receiving your contributions.

Dr. Andreia Cristina de Melo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HPV vaccination
  • screening
  • cervical cancer
  • prevention

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 883 KiB  
Article
A Computational Framework Analysis of Public Attitudes Toward Male Human Papillomavirus Infection and Its Vaccination in China: Based on Weibo Data
by Xuan Zhou, Hao Gao and Jun Wang
Healthcare 2025, 13(3), 287; https://doi.org/10.3390/healthcare13030287 - 31 Jan 2025
Viewed by 762
Abstract
Background/Aims: The global promotion of HPV vaccines has underscored the importance of vaccination for both males and females in reducing disease transmission and associated complications. Despite robust evidence supporting male HPV vaccination, China has yet to approve it. Public discussions on male HPV [...] Read more.
Background/Aims: The global promotion of HPV vaccines has underscored the importance of vaccination for both males and females in reducing disease transmission and associated complications. Despite robust evidence supporting male HPV vaccination, China has yet to approve it. Public discussions on male HPV vaccination, influenced by policy delays, gender norms, and commercialization, reveal diverse attitudes and significant challenges in achieving equitable health outcomes. This study investigates public perceptions and attitudes toward male HPV vaccination in China by analyzing cognitive frames and the social, cultural, and economic factors shaping these discussions. Methods: This study employs a cross-sectional design to analyze 4997 Sina Weibo posts using the Analysis of Topic Model Networks (ANTMN), identifying five frames: Disease Risk and Prevention, Virus Transmission, Gender Roles and Perceptions, Vaccine Promotion and Acceptance, and Market Dynamics and Consumption. Results: The findings reveal a significant gap between policy implementation and public awareness of male HPV vaccination in China. Despite growing recognition of its benefits, entrenched gender norms and biases hinder equitable health outcomes. Social media, as a pivotal platform for health communication, plays a dual role in facilitating public discourse while also amplifying misinformation. Policy delays and concerns over vaccine commercialization heighten public hesitancy, emphasizing the need for inclusive policies and targeted education. Conclusions: This study highlights the necessity for systemic efforts to address gender biases, enhance public education on male HPV vaccination, and rebuild trust in vaccination programs. A multifaceted approach is required to bridge these gaps, integrating policy reforms, inclusive health communication strategies, and equitable vaccine access. These measures aim to promote awareness and increase vaccination uptake among males in China, ultimately contributing to more comprehensive and equitable public health outcomes. Full article
(This article belongs to the Special Issue HPV Vaccine and Cervical Cancer Prevention)
Show Figures

Figure 1

Back to TopTop